Please assess the completion status of the following clinical trial:

Trial Title: Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient has history of physician diagnosed asthma~* Patient is in otherwise good stable health~* Patient is able to chew a tablet~Exclusion Criteria:~* Patient is hospitalized~* Patient and/or parent of guardian intends to move or vacation away from home during the course of the study~* Patient had any major surgical procedure within 4 weeks before the study~* Patient had active sinus disease within 3 weeks before the study~* Patient had required intubation for asthma in the past~* Patient required a visit to the emergency room due to an asthma exacerbation, or has been hospitalized for asthma with in 1 month prior to the study~* Patient had used inhaled, nebulized, intramuscular, or intravenous steroids with in 1 month before study

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 5 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Montelukast
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).